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European Biotechnology Developments
Several plenary talks discussed the current status and trends in 
european biotechnology including education in biotechnology 
(2, 4, 5). it was reported that for 2010 the revenues from the 
european biotechnology increased with 13% and the R&D 
expenditure increased with 5%. UK and Germany are the 
leading nations in the field but there is a noticeable shift in 
turkey and Russia. Biotechnology and pharmaceutical are 
the european industries that increase faster than any other 
industries. cancer is the fastest growing clinical segment. 
each and every country in europe invests quite considerable 
amounts into public R&D, including biotech research and 
development. the funding criteria differ across member states, 
but the general idea is similar: to advance the knowledge pool 
of the human kind and to prepare for the forthcoming bio-
economy. Policies to support knowledge transfer from research 
to industry include: creating collaboration activities between 
enterprises and research institutions; introducing regional 
grants for industrial research and pre-competitive development; 
creating link between science and economy and support for 
University researchers to create companies. the role of life 
sciences education to develop graduates able to meet a wide 
variety of future economic, societal and technological needs 
was also discussed at the congress.
Systems Biology and Biotechnology
Undoubtedly one of the hot topics at the congress was the 
application of systems biology to biotechnology (1, 3, 6, 8). 
Systems Biology is defined as the quantitative analysis of 
the dynamic interactions between several components of a 
biological system and aims to understand the behaviour of the 
system as a whole, as opposed to the behaviour of its individual 
constituents. it applies the concepts of systems engineering 
to the study of complex biological systems through iteration 
between computational and/or mathematical modelling 
and experimentation. Several presentations discussed the 
application of systems biology to biomedical research, which 
can be used for rational target identification (7), prediction and 
avoidance of adverse properties of therapeutics and monitoring 
of clinical efficacy using surrogate markers and individualized 
approaches to disease treatment (6). one of the challenges 
of systems biology is to integrate biology, technology and 
computation. once this is achieved it will lead to a great 
potential of applications in biotechnology and medicine.
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ABSTRACT
The European Biotechnology Congress 2011 was held in Istanbul between the 28th of September and the 1st of October 2011. 
The Congress was organised by the European Biotechnology Thematic Network Association (EBTNA) in conjunction with the 
Turkish Medical Genetics Association and under the aegis of the Presidency of the Republic of Turkey. The Congress attracted 
scientists not only from Europe but from across the globe. The main topics covered by the congress were: Medical Genetics, 
Plant Biotechnology, Industrial Biotechnology, Animal Biotechnology, Regenerative Medicine and Stem Cells, Environmental 
Biotechnology, Biotechnologies in Infectious and Parasitic Diseases, Nanobiotechnology, Pharmaceutical Biotechnology, 
Bioinformatics, Assisted Reproductive Methods in Biotechnology, Education and Biotechnology. The application of systems 
biology approaches to biotechnology emerged as one of the main themes in many sections.
